CSI Market
Sign In | Register

Newamsterdam Pharma N v (NAMS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NAMS Annual Balance Sheets →
A period-by-period view of the balance sheet from Newamsterdam Pharma N v to Sep 30 2025 helps clarify how Sep 30 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NAMS/balance-sheets
https://api.csimarket.com/api/v1/companies/NAMS/fundamentals
https://api.csimarket.com/api/v1/companies/NAMS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent423.13
Restricted Cash1.50
Marketable Securities, Current SH205.11
Cash & Short-term Investments628.00
Other Receivables8.52
Notes Receivable, Current0.30
Other Current Assets0.00
Prepaid Expense And Other Assets Current44.17
Total Current Assets672.16
Equipment/Property/Plant Net0.55
Intangible Assets0.31
Long-term investments14.88
Tax Assets, Noncurrent0.00
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent0.08
Restricted Cash Current1.34
Operating Lease Right Of Use Asset0.02
Total Assets687.99
Liabilities
Accounts Payable, Current AC4.63
Accrued Liabilities, Current10.46
Derivative Liability, Current DE31.33
Other Liabilities, Current5.03
Deferred Revenue, Current DE5.71
Total Current Liabilities57.15
Total Long-term Debt0.00
Other liabilities, Noncurrent0.05
Operating Lease Liability Current0.02
Operating Lease Liability Noncurrent-
Total Liabilities57.20
Stockholders' Equity
Common Stock Value15.03
Additional Paid In Capital Common Stock1,504.48
Retained Earnings / Accumulated Deficit-892.36
Accumulated Other Comprehensive Income3.62
Other Equity3.62
Common Stockholder's Equity630.78
Total Stockholder's Equity630.78
Liabilities & Stockholder's Equity687.99
4 historic quarters locked

Sign in to unlock the full Newamsterdam Pharma N v balance sheet history.

Sign In Create Free Account

About Newamsterdam Pharma Co N V Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-446228

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI